期刊文献+

腺病毒介导的小鼠可溶性endoglin和可溶性血管内皮生长因子受体-1重组蛋白的构建和功能初步鉴定

Construction and function identification of recombinant mouse soluble endoglin and soluble fms-like tyrosine kinase-1 mediated by adenovirus
原文传递
导出
摘要 目的构建腺病毒介导的小鼠可溶性endoglin(sEng)和可溶性血管内皮生长因子受体-1(sFlt-1)重组蛋白,观察其对内皮细胞管化及滋养细胞迁移的影响。方法提取小鼠胎盘组织总RNA,通过RT—PCR获得sEng和sFlt-1 cDNA,插入到穿梭载体pAdTrack—CMV中,获得pATC-sEng和pATC—sFh-1质粒,转化其至pAdeasy-1受体菌,选阳性克隆转染293A细胞,获得Ad/sEng和Ad/sFlt-1,制备高滴度病毒液。用病毒感染COS7细胞,检测sEng和sFlt-1蛋白表达,并通过成管和划痕实验观察两种蛋白对人脐静脉血管内皮细胞(HUVEC)管化和Bewo细胞迁移的影响。结果成功获得sEng和sFlt-1重组腺病毒,其滴度分别为2.2×10^11pfu/ml和2.0X10^11pfu/ml。感染COS7细胞后,sEng和sFlt-1蛋白均较高表达,并能抑制HUVEC管化及Bewo细胞迁移,两者有协同作用。结论构建的腺病毒介导的小鼠sEng和sFlt-1重组蛋白对血管生成和滋养细胞迁移有明显抑制作用。 Objective To construct the recombinant adenovirus Ad/sEng and Ad/sFlt-1, and investigate their effects on angiogenesis and the migration of human umbilical vein endothelial cells (HUVEC) and trophoblast. Methods The sEng and sFlt-1 cDNA were obtained from mouse placenta by RT-PCR, which were inserted into the shuttle plasmid pAdTrack-CMV. After confirmation by endonuclease and sequencing, we transferred them into Escherichia coll. BJ5183- AD-1 cells were applied to obtain the homologous recombinants, which were transfected into 293A cells to obtain Ad/sEng and Ad/sFlt-1, and COS7 cells were infected with them. The expressions of sFlt-I and sEng were detected by Western blot. The effects of both proteins on HUVEC tube formation and BeWo migration were investigated. Results High titers of Ad/sEng and Ad/sFlt-1 were obtained (2.2 ×10^11 pfu /ml and 2. 0× 10^11 pfu/ml, respectively) and both sFlt1 and sEng proteins were efficiently expressed, which inhibited the HUVEC tube formation and BeWo cell migration. Conclusions Adenovirus mediated mouse sFlt-1 and sEng has been constructed and expressed successfully in vitro with inhibitory effects on angiogenesis and the migration of HUVEC and trophoblast.
出处 《中华围产医学杂志》 CAS 2009年第6期425-429,共5页 Chinese Journal of Perinatal Medicine
基金 国家自然科学基金项目(30872775) 江苏省兴卫工程领军人才项目(LJ200628) 江苏省医学分子技术重点实验室(BM2007208) 江苏省生殖健康公共技术服务中心(BM2008151)
关键词 先兆子痢 细胞内信号肽和蛋白质类 血管内皮生长因子受体1 重组蛋白质类 腺病毒科 Pre-eclampsia Intracellular signaling peptides and proteins Vascular endothelial growth factor receptor-1 Recombinant proteins Adenoviridae vector
  • 相关文献

参考文献8

  • 1Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med, 2004,350:672-683.
  • 2朱毓纯,孙瑜,杨慧霞,廖秦平.孕妇血清中可溶性endoglin水平变化与重度子痫前期及子痫患者发病的关系[J].中华妇产科杂志,2009,44(2):91-93. 被引量:12
  • 3Barleon B, Totzke F, Herzog C, et al. Mapping of sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor Fit-1. J BiolChem, 1997,272:10382-10388.
  • 4Venkatesha S, Toporsian M, Lain C,et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med, 2006,12:642 -649.
  • 5Sun H,Chen L,Yan G, et al. HOXA 10 suppresses p/CAF promoter activity via three consecutive TTAT units in human endometrial stromal cells. Biocbem Biophys Res Commus, 2009,379:16-21.
  • 6Thompson CC, Ashcroft FJ, Patel S, et al. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility. Gut, 2007,56:95-106.
  • 7Gougos A, Letarte M. Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem,1990,265: 8361-8364.
  • 8Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA, 1993, 90: 10705-10709.

二级参考文献6

  • 1Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med, 2006,355 : 992-1005.
  • 2Fonsatti E, Sigalotti L, Arslan P, et al. Emerging role of endoglin (CD105) as a marker of angiogenesis with clinical potential in human malignancies. Curr Cancer Drug Targets, 2003, 3:427- 432.
  • 3Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med, 2006, 12:642-649.
  • 4Staff AC, Braekke K, Johnsen GM, et al. Circulating concentrations of soluble endoglin ( CD105 ) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol,2007,197 : 176.
  • 5Salahuddin S, Lee Y, Vadnais M, et al. Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstect Gynecol, 2007, 197:28.
  • 6Robinson C J, Johnson DD. Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol, 2007,197 : 174.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部